Research Article

AT7867 Inhibits the Growth of Colorectal Cancer Stem-Like Cells and Stemness by Regulating the Stem Cell Maintenance Factor Ascl2 and Akt Signaling

Figure 9

In CRC-derived CSCs, Survivin was activated. compared with the Akt inhibitor miltefosine, AT7867 has a stronger ability to inhibit stemness. (a) Western blot detected the parental cells, the fifth spheres, and treatment of the fifth spheres in a different dose of AT7867 expression of Survivin. (b) Representative morphology after AT7867 and miltefosine treatment. (c) The expression of Ascl2 and Survivin was detected by Western blotting. , , and .
(a)
(b)
(c)
(d)